Logo

Bruker Registers Mass Specs with Korean Regulators as Medical Devices for IVD Apps

Aug 10, 2005

NEW YORK, Aug. 10 (GenomeWeb News) - Bruker Daltonics has registered its autoflex II MALDI-TOF mass spectrometers as class I medical devices with the Korean Food and Drug Administration, the company said today.

 

The registration helps Bruker's customers obtain regulatory approval for mass spectrometry-based in vitro diagnostic methods they developed, according to the company.

 

The mass spectrometers are already being used by GeneMatrix of Korea for molecular diagnostics applications, which the company offers to medical centers and university hospitals in Korea, according to Bruker. The autoflex II instruments are also part of Bruker's ClinProt system for peptide and protein biomarker profiling.

Breaking News
The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.